SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022426
Filing Date
2024-08-28
Accepted
2024-08-28 16:15:11
Documents
1
Period of Report
2024-08-26

Document Format Files

Seq Description Document Type Size
1 form4-08282024_040807.html 4  
1 form4-08282024_040807.xml 4 5957
  Complete submission text file 0001415889-24-022426.txt   7449
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Issuer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Goldenberg Gary (Reporting) CIK: 0001741938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38529 | Film No.: 241255647